Telix Pharmaceuticals Limited (ASX: TLX, Nasdaq: TLX, Telix, the Company) today announces that the United Kingdom (UK) Medicines and Healthcare Products Regulatory Agency (MHRA) has approved the ...

Strong early U.S. YORVIPATH® launch with 908 prescriptions as of Feb. 7, 2025; YORVIPATH full year 2024 revenue of €28.7 million– Following ...

AB (market cap: $16.28M), a company in the development stage, provided insights into its Q4 2024 performance and future plans during its recent earnings call. The company is advancing its Neola ...

Implantica AG (publ.), a medtech company at the forefront of introducing advanced technology into the body, including a unique device RefluxStop™ for the treatment of acid reflux, a treatment field ...

Biogen expects Leqembi and new rare disease and depression treatments to help offset revenue lost from multiple sclerosis ...

One might think that a pharmaceutical ingredients company that boasts clients in 80 countries, certification from several ...

Indiana-based firm FGF, LLC, said that its nationwide FDA recall of 60 baked goods over Listeria risk, including certain ...

An advocacy group criticizes Hims & Hers Health for allegedly misleading Super Bowl ad promoting weight loss products, violating FDA regulations. Read more here.

Citizens Financial Group (CFG) is scheduled to report earnings on April 16, 2025. The last reported earnings were for reported on January 17, 2025 for Q4.

New York-based VJ Group announced the launch of its newest venture, VJ Bio, a biotech company dedicated to creating an ...

In a statement, Dr. Jacqueline Corrigan-Curay, the acting director for the FDA's Center for Drug Evaluation and Research ...

Jan. 28, 2025 /PRNewswire/ -- Instylla, Inc., a privately held clinical-stage company developing solutions for peripheral vascular embolotherapy, has announced the FDA 510(k) clearance of the ...